Section Arrow
AZN.NYSE
- AstraZeneca PLC
Quotes are at least 15-min delayed:2026/04/25 05:36 EDT
Regular Hours
Last
 189.75
-2.55 (-1.33%)
Day High 
189.94 
Prev. Close
192.3 
1-M High
207.3 
Volume 
2.39M 
Bid
189.01
Ask
195.13
Day Low
187.56 
Open
189.15 
1-M Low
182.39 
Market Cap 
298.23B 
Currency 美元 
P/E 29.45 
%Yield 1.24 
10-SMA 200.07 
20-SMA 199.04 
50-SMA 198.44 
52-W High 212.71 
52-W Low 131.03 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
6.54/13.16
Enterprise Value
324.36B
Balance Sheet
Book Value Per Share
31.38
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
24.38B
Operating Revenue Per Share
37.88
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFEPfizer27+0.33+1.24%19.61PE
OGNOrganon & Co11.26+2.66+30.93%11.87PE
NVONovo-Nordisk A/S41.17+2.65+6.88%10.72PE
ABBVABBVIE198.71-2.24-1.11%84.84PE
MRKMerck & Co111.9-2.72-2.37%15.67PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.